|
Volumn 146, Issue 9, 2007, Pages 682-683
|
Trials that matter: CD4+ T-lymphocyte count-guided interruption of antiretroviral therapy in HIV-infected patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
VIRUS RNA;
AUTOIMMUNITY;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
DRUG EXPOSURE;
DRUG SAFETY;
EDITORIAL;
HOSPITALIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
PATIENT MONITORING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
VIRUS REPLICATION;
CONTROLLED CLINICAL TRIAL;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
IMMUNOLOGY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT WITHDRAWAL;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
HIV INFECTIONS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
WITHHOLDING TREATMENT;
|
EID: 34248379195
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-146-9-200705010-00014 Document Type: Editorial |
Times cited : (5)
|
References (15)
|